2014 | Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection?
| WORLD JOURNAL OF GASTROENTEROLOGY |
2021 | Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques
| FRONTIERS IN ONCOLOGY |
2016 | Postoperative irradiation after implant placement: A pilot study for prosthetic reconstruction
| JOURNAL OF ADVANCED PROSTHODONTICS |
2014 | Postoperative radiotherapy dose correlates with locoregional control in patients with locoregional control in patients with extra-hepatic bile duct cancer
| RADIATION ONCOLOGY JOURNAL |
2020 | Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01) | RADIOTHERAPY AND ONCOLOGY |
2014 | Postoperative radiotherapy in salivary ductal carcinoma: a single institution experience
| RADIATION ONCOLOGY JOURNAL |
2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | JOURNAL OF GASTROINTESTINAL SURGERY |
1997 | Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha | ANTI-CANCER DRUGS |
2021 | Practical aspects of the application of helical tomotherapy for craniospinal irradiation
| SCIENTIFIC REPORTS |
2019 | Practical effectiveness of re-irradiation with or without surgery for locoregional recurrence of rectal cancer: A meta-analysis and systematic review | RADIOTHERAPY AND ONCOLOGY |
2018 | Practical Implementation of Patient-Specific Quality Assurance for Small and Multiple Brain Tumors in CyberKnife with Fixed Collimators
| Korean Journal of Medical Physics (의학물리) |
2014 | Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme linked immunosorbent assays (ELISAs) for biomarkers | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2022 | Predicting treatment outcomes using 18 F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
2021 | Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
| FRONTIERS IN ONCOLOGY |
2015 | Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma
| GUT AND LIVER |
2017 | Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
| RADIATION ONCOLOGY JOURNAL |
2020 | Predictive value of interim 18F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy
| PLOS ONE |
2006 | Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer | OTOLARYNGOLOGY-HEAD AND NECK SURGERY |
2018 | Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy
| WORLD JOURNAL OF GASTROENTEROLOGY |
2022 | Preliminary study for dose evaluation depending on dose range with optically stimulated luminescence dosimeter considering individual dosimeter sensitivity
| PLOS ONE |